HIV Statistics: Global Prevalence, Regional Variations & Key Populations

HIV remains a major global health challenge. According to UNAIDS 2021 data:

Global Statistics

  • People living with HIV (PLHIV): 38.4 million (slight increase from 2020 due to longer survival on ART)
  • New HIV infections: 1.5 million (~4,000 daily)—a 32% decline since 2010, but far from the 2025 target of <370,000
  • AIDS-related deaths: 650,000—a 52% decline since 2010 peak
  • Access to antiretroviral therapy (ART): 28.7 million (75% of PLHIV)—up from 7.8 million in 2010
  • Viral suppression: 68% of PLHIV globally

Regional Variations

  • Eastern & Southern Africa: Epicenter—20.6 million PLHIV (54% of global total); 670,000 new infections; 280,000 deaths. South Africa, Mozambique, Tanzania, Uganda, Kenya heavily affected. Women and girls disproportionately impacted.
  • Western & Central Africa: 4.9 million PLHIV; lower ART coverage (73% vs. 84% in E. Africa); key populations disproportionately affected.
  • Asia & Pacific: 6 million PLHIV; 260,000 new infections. Concentrated epidemics in key populations. India has the 3rd largest HIV population globally (~2.4 million).
  • Eastern Europe & Central Asia: 1.8 million PLHIV; 160,000 new infections (48% increase since 2010). Driven by injection drug use, stigma, punitive laws, limited harm reduction.
  • Latin America: 2.2 million PLHIV; 110,000 new infections. Concentrated in MSM and transgender women.
  • Western & Central Europe & North America: 2.3 million PLHIV; 58,000 new infections. High ART coverage (88%) and viral suppression (81%). Disparities persist by race/ethnicity and geography.
  • Middle East & North Africa: 180,000 PLHIV; 16,000 new infections. Lowest ART coverage (50%); rising epidemics in key populations.

Key Populations Disproportionately Affected

Key populations (KPs) and their sexual partners accounted for 70% of new infections globally in 2021:

  • Men who have sex with men (MSM): 28x higher risk than general male population
  • People who inject drugs (PWID): 35x higher risk
  • Sex workers: 30x higher risk
  • Transgender people: 14x higher risk
  • People in prisons/closed settings: Higher prevalence, limited services

Stigma, discrimination, criminalization, and lack of tailored services drive these disparities.

Progress & Challenges

  • Treatment advances: ART suppresses virus to undetectable levels (U=U: Undetectable = Untransmittable), enabling long, healthy lives and preventing transmission. Long-acting injectable ART (cabotegravir/rilpivirine) improves adherence.
  • Prevention tools: PrEP (oral, injectable), PEP, condoms, VMMC, harm reduction, treatment as prevention.
  • Persistent barriers: Stigma, discrimination, gender inequality, punitive laws, funding gaps, health system weaknesses, commodity stockouts.
  • 2025 Targets (UNAIDS 95-95-95): 95% diagnosed, 95% on ART, 95% virally suppressed. Requires accelerated, equitable action.

HIV & AIDS - Related Articles